Skip to content
DataLookout
Menu

NCT06630377

GOS and the Management of Hyperuricemia

StatusUnknown
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Change of serum uric acid
Timeframe: from baseline to 8 weeks after intervention
Change of excretion of uric acid
Timeframe: from baseline to 8 weeks after intervention

Secondary (2)

Change of gut microbiota
Change of microbial metabolites in the circulation

Arms and interventions

Dietary intervention with GOSExperimental

Eligible subjects are instructed to take one pocket of galactooligosaccharide during the first week, followed by two pockets of galactooligosaccharide during the remaining 7 weeks.

Dietary intervention with PlaceboPlacebo comparator

Eligible subjects are instructed to take one pocket of maltodextrin during the first week, followed by two pockets of maltodextrin during the remaining 7 weeks.

Dietary supplements: GOS, Placebo

Sites

1 site in 1 country

  • Sun Yat-Sen UniversityGuangzhou, Guangdong, China